It is established that adequate calcium intake is critical to achieving optimal peak bone mass and modifies the rate of bone loss associated with aging. Numerous studies have shown that acid production decreases with age, making it difficult to absorb calcium. The increased bioavailability and additive vascular benefits of calcium taurate may prove this to be an ideal delivery form of supplementation for the senior market. It is estimated that osteoporosis affects more than 25 million people in the United States and is the major underlying cause of bone fractures in postmenopausal women and the elderly, while hypertension affects more than half of all Americans over the age of 65. Forward-looking statements are based on the company's current expectations and are subject to market, competitive and regulatory factors and the other risks and uncertainties indicated from time to time in the company's filings with the Securities and Exchange Commission.
Actual results can differ materially.
The company makes no commitment to disclose any revisions to forward-looking statements. The Net - Business Wire's full file on the Internet with Hyperlinks to your home page. 2001 Business Wire. All Rights Reserved.